VALIDATING THE RESULTS OF A MATCHING ADJUSTED INDIRECT COMPARISON (MAIC) IN MET EXON 14 (METEX14) SKIPPING NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Hatswell, A. [1 ]
Batteson, R. [1 ]
Hook, E. [1 ]
Wheat, H. [1 ]
Vioix, H. [2 ]
McLean, T. [3 ]
Alexopoulos, S. [3 ]
Baijal, S. [4 ]
机构：
[1] Delta Hat Ltd, Nottingham, England
[2] Merck Healthcare KGaA, Darmstadt, Germany
[3] Merck Serono Ltd, Feltham, England
[4] Univ Hosp Birmingham NHS Trust, Birmingham, W Midlands, England
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO23
引用
收藏
页码：S21 / S22
页数：2
相关论文
共 50 条
  • [21] Clinical and genomic analysis of non-small cell lung cancer (NSCLC) patients with MET exon14 skipping (METex14) mutations and responses to anti-MET therapy.
    McKenzie, Andrew
    Fisher, Arielle
    Correll, Mick
    Jones, Carissa
    Correia, Jessica
    Thurber, James
    Misch, Amanda
    Heritage, Jessica
    Sturgill, Emma
    Jones, Suzanne Fields
    Johnson, Melissa Lynne
    Spigel, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Therapeutic strategies in METex14 skipping mutated non-small cell lung cancer
    Leylah M. Drusbosky
    Richa Dawar
    Estelamari Rodriguez
    Chukwuemeka V. Ikpeazu
    Journal of Hematology & Oncology, 14
  • [23] Matching-Adjusted Indirect Comparison (MAIC) of Tepotinib with Other MET Inhibitors for the Treatment of Advanced NSCLC with MET Exon 14 Skipping Mutations
    Paul K. Paik
    Boris M. Pfeiffer
    Helene Vioix
    Andrea Garcia
    Maarten J. Postma
    Advances in Therapy, 2022, 39 : 3159 - 3179
  • [24] Matching-Adjusted Indirect Comparison (MAIC) of Tepotinib with Other MET Inhibitors for the Treatment of Advanced NSCLC with MET Exon 14 Skipping Mutations
    Paik, Paul K.
    Pfeiffer, Boris M.
    Vioix, Helene
    Garcia, Andrea
    Postma, Maarten J.
    ADVANCES IN THERAPY, 2022, 39 (07) : 3159 - 3179
  • [25] Tepotinib in Asian patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping
    Yang, J. C-H.
    Le, X.
    Cho, B. C.
    Han, J-Y.
    Morise, M.
    Chen, Y-M.
    Kang, J-H.
    Kato, T.
    Takeoka, H.
    Chikamori, K.
    Sakai, H.
    Park, K.
    Wu, Y-L.
    Schumacher, K.
    Bruns, R.
    Straub, J.
    Paik, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S1390 - S1391
  • [26] Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping.
    Kato, Terufumi
    Yang, James Chih-Hsin
    Ahn, Myung-Ju
    Sakai, Hiroshi
    Morise, Masahiro
    Chen, Yuh-Min
    Han, Ji-Youn
    Yang, Jin-Ji
    Zhao, Jun
    Huang, Jason
    Berghoff, Karin
    Bruns, Rolf
    Vioix, Helene
    Otto, Gordon
    Le, Xiuning
    Paik, Paul K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] MET Exon 14 Skipping in Non-Small Cell Lung Cancer
    Heist, Rebecca S.
    Shim, Hyo Sup
    Gingipally, Shalini
    Mino-Kenudson, Mari
    Le, Long
    Gainor, Justin F.
    Zheng, Zongli
    Aryee, Martin
    Xia, Junfeng
    Jia, Peilin
    Jin, Hailing
    Zhao, Zhongming
    Pao, Gwilliam
    Engelman, Jeffrey A.
    Iafrate, A. John
    ONCOLOGIST, 2016, 21 (04): : 481 - 486
  • [28] Tepotinib safety in MET exon 14 (METex14) skipping NSCLC: Updated results from the VISION trial
    Morise, Masahiro
    Sakai, Hiroshi
    Veillon, Remi
    Le, Xiuning
    Felip, Enriqueta
    Garassino, Marina Chiara
    Cortot, Alexis B.
    Smit, Egbert
    Park, Keunchil
    Griesinger, Frank
    Britschgi, Christian
    Wu, Yi-Long
    Berghoff, Karin
    Otto, Gordon
    Bruns, Rolf
    Paik, Paul
    ANNALS OF ONCOLOGY, 2021, 32 : S291 - S291
  • [29] Real-world assessment of treatment effectiveness in patients with advanced non-small cell lung cancer (aNSCLC) with MET exon 14 skipping (METex14)
    Furqan, Muhammad
    Karanth, Siddharth
    Goyal, Ravi K.
    Shih, Yu-Hsuan
    Cai, Beilei
    Rombi, Julien
    Davis, Keith L.
    Caro, Nydia
    Saliba, Teddy Rassem
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Tepotinib Safety in MET Exon 14 (METex14) Skipping NSCLC: Updated Results from the VISION Trial
    Veillon, R.
    Sakai, H.
    Le, X.
    Felip, E.
    Garassino, M. C.
    Cortot, A.
    Smit, E.
    Park, K.
    Griesinger, F.
    Britschgi, C.
    Wu, Y.
    Berghoff, K.
    Otto, G.
    Bruns, R.
    Paik, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S231 - S231
12345